Hervolution Therapeutics
Operator of a biotechnology company intended to treat cancer by targeting tumor viruses within the human genome. The company offers broad and curative cancer therapy in combination with immune checkpo...
Valuation
$28.1M
Market implied
Share Price
N/A
Total Raised
$15.7M
Last Round
N/A